Weill Cornell Medicine Events

Dean’s Inaugural Symposium On Opportunities for Entrepreneurship and Academic Drug Development

Augustine M.K. Choi, M.D.

invites you to the

Dean’s Inaugural Symposium
On Opportunities for
Entrepreneurship and Academic Drug Development


Featuring a keynote address by Kenneth Frazier, Chairman and CEO of Merck, and presentations on the Tri-I TDI, Bridge Medicines, Center for Technology Licensing, and Office of BioPharma Alliances and Research Collaborations.


Monday, October 9, 2017
2 p.m. – 4 p.m.

Uris Auditorium, Meyer Building, 1300 York Avenue
Reception to follow in Griffis Faculty Club, 4 p.m. – 5 p.m.


Please RSVP to sng3001@med.cornell.edu or (646) 962-9478.

The symposium will be recorded and available to individuals on WCM Central.




2 p.m.  Welcome

Augustine M.K. Choi, M.D., Stephen and Suzanne Weiss Dean, Weill Cornell Medicine

2:15 p.m. Pharmaceutical Product Development: The Case for Investing in Invention

Kenneth C. Frazier, Chairman of the Board and CEO, Merck & Co., Inc.

2:40 p.m. Tri-I TDI: Transforming Academic Drug Discovery and Development

Michael A. Foley, Ph.D., Sanders Director of the Tri-Institutional Therapeutics Drug Discovery Institute

2:50 p.m. Therapeutic Targeting of Sphingolipid Signaling in Preclinical Models of Stroke: The Critical Role of the Tri-I TDI

Teresa Sanchez, Ph.D., Assistant Professor of Pathology and Laboratory Medicine

3 p.m. Bridge Medicines: Industry Expertise for Bridging the Gap to Clinical Studies

William J. Polvino, M.D., Chief Executive Officer, Bridge Medicines

3:10 p.m. Commercializing Technology with CTL: What’s in it for You?

Brian J. Kelly, Ph.D., Director, Technology Licensing, WCM Office of the Center for Technology Licensing

3:20 p.m. BioPharma Alliances and Research Collaborations: Building Value Around Early Stage Discovery Research through Dedicated Alliances with Industry

Larry Schlossman, Managing Director, BioPharma Alliances and Research Collaborations                                           

3:30 p.m. The Critical Importance of BioPharma Alliances in Support of Early Stage Translational Research     

Timothy E. McGraw, Ph.D., Professor of Biochemistry and of Biochemistry in Cardiothoracic Surgery

3:40 p.m. Q&A

Moderated by Dr. Augustine M.K. Choi

4 p.m. Conclusion

Reception to follow in Griffis Faculty Club

Monday, October 9, 2017 at 2:00pm to 5:00pm

Uris Auditorium
1300 York Ave., New York NY 10065

Event Type

Conference, Lecture/Seminar, Party/Reception, Translational Lecture/Seminar, Information Session, Symposium


Office of the Dean, Meyer Cancer Center



Google Calendar iCal Outlook

Recent Activity